Search

everythinglearnresearchcommunity

for

Search:↓

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

A woman with lupus and severe nerve damage improved with specific treatments.

Low BMI and cold exposure increase the risk of chilblains.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Men with androgenetic alopecia, or hair loss, often have abnormal blood flow in their small blood vessels, which might be linked to inflammation and stress.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tph cells are linked to the severity of systemic lupus erythematosus.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Accurate diagnosis of progressive supranuclear palsy requires thorough neurological assessments and MRI.

Lupus can be a rare cause of high calcium levels in the blood.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Lupus patients' body image issues significantly affect their mental health and need more support.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Leflunomide is more likely to help treat alopecia areata than cause it.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Lupus can cause unusual vision problems, so it's important to consider it in such cases.